abstract |
The present invention relates to regulation Sirtuin (SIRT) expression and/or function, the ASON being adjusted especially by targeting Sirtuin (SIRT) natural antisense polynucleotides.The invention further relates to the discriminating of the ASON and its purposes in the treatment disease and illness relevant with Sirtuin (SIRT) expression. |